STATE STREET CORP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,480,660
-19.8%
3,065,967
+0.8%
0.00%0.0%
Q2 2023$25,521,256
+1383.2%
3,041,866
+1655.5%
0.00%
Q1 2023$1,720,680
-28.7%
173,281
-50.0%
0.00%
Q4 2022$2,412,072
+159.6%
346,562
+99.3%
0.00%
Q3 2022$929,000
+33.9%
173,8810.0%0.00%
Q2 2022$694,000
-82.2%
173,881
-80.2%
0.00%
Q1 2022$3,902,000
-68.4%
877,797
-71.5%
0.00%
-100.0%
Q4 2021$12,329,000
-59.0%
3,082,352
-10.1%
0.00%
-50.0%
Q3 2021$30,092,000
-15.2%
3,427,379
+9.4%
0.00%0.0%
Q2 2021$35,498,000
+23.3%
3,133,139
+29.3%
0.00%0.0%
Q1 2021$28,786,000
+20171.8%
2,423,024
+11605.4%
0.00%
Q4 2020$142,0000.0%20,700
+8.4%
0.00%
Q3 2020$142,000
+77.5%
19,1000.0%0.00%
Q2 2020$80,000
-92.0%
19,100
-95.3%
0.00%
Q1 2020$995,000
-59.0%
403,009
-3.4%
0.00%
Q4 2019$2,424,000
+15.3%
417,207
+4.6%
0.00%
Q3 2019$2,102,000
-12.2%
398,856
-0.1%
0.00%
Q2 2019$2,395,000
-25.3%
399,208
+12.4%
0.00%
Q1 2019$3,207,000
+35.8%
355,202
+24.9%
0.00%
Q4 2018$2,361,000
-30.7%
284,480
+15.3%
0.00%
Q3 2018$3,406,000
+81.1%
246,790
+4.3%
0.00%
Q2 2018$1,881,000
+869.6%
236,626
+812.5%
0.00%
Q1 2018$194,000
+25.2%
25,931
+14.4%
0.00%
Q4 2017$155,000
+16.5%
22,669
+22.5%
0.00%
Q3 2017$133,00018,5000.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders